LISATA THERAPEUTICS, INC. financial data

Symbol
LSTA on Nasdaq
Location
Basking Ridge, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 599% % -30%
Debt-to-equity 20% % 50%
Return On Equity -79% % -54%
Return On Assets -66% % -46%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8,820,733 shares 5.1%
Common Stock, Shares, Outstanding 8,755,948 shares 5.2%
Entity Public Float $27,700,000 USD 10%
Common Stock, Value, Issued $9,000 USD 12%
Weighted Average Number of Shares Outstanding, Basic 8,738,000 shares 5%
Weighted Average Number of Shares Outstanding, Diluted 8,738,000 shares 5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,070,000 USD
Operating Income (Loss) $20,078,000 USD 15%
Nonoperating Income (Expense) $874,000 USD -55%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $19,204,000 USD 11%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $18,242,000 USD 12%
Earnings Per Share, Basic -2 USD/shares 15%
Earnings Per Share, Diluted -2 USD/shares 15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $18,998,000 USD -2.6%
Cash, Cash Equivalents, and Short-term Investments $14,492,000 USD -52%
Accounts Receivable, after Allowance for Credit Loss, Current $900,000 USD
Assets, Current $21,575,000 USD -43%
Property, Plant and Equipment, Net $22,000 USD -77%
Operating Lease, Right-of-Use Asset $0 USD -100%
Intangible Assets, Net (Excluding Goodwill) $400,000 USD 0%
Other Assets, Noncurrent $23,000 USD -89%
Assets $21,759,000 USD -43%
Accounts Payable, Current $619,000 USD 11%
Employee-related Liabilities, Current $2,116,000 USD -0.61%
Accrued Liabilities, Current $3,949,000 USD -4.5%
Liabilities, Current $4,568,000 USD -2.6%
Operating Lease, Liability, Noncurrent $0 USD -100%
Other Liabilities, Noncurrent $72,000 USD 0%
Liabilities $4,640,000 USD -2.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax $42,000 USD -31%
Retained Earnings (Accumulated Deficit) $561,698,000 USD -3.4%
Stockholders' Equity Attributable to Parent $17,373,000 USD -48%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $17,119,000 USD -49%
Liabilities and Equity $21,759,000 USD -43%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $5,402,000 USD 23%
Net Cash Provided by (Used in) Financing Activities $23,000 USD 84%
Net Cash Provided by (Used in) Investing Activities $9,431,000 USD 47%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 8,756,686 shares 5.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $4,008,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18,998,000 USD -2.6%
Deferred Tax Assets, Valuation Allowance $27,794,000 USD 18%
Deferred Tax Assets, Gross $27,833,000 USD 18%
Operating Lease, Liability $0 USD -100%
Depreciation $26,000 USD -10%
Payments to Acquire Property, Plant, and Equipment $28,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $18,252,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid $0 USD -100%
Property, Plant and Equipment, Gross $494,000 USD -25%
Operating Lease, Liability, Current $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One $143,000 USD -25%
Operating Lease, Weighted Average Discount Rate, Percent 0 pure -104%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards $16,062,000 USD 26%
Unrecognized Tax Benefits $344,000 USD 0%
Additional Paid in Capital $579,812,000 USD 0.34%
Amortization of Intangible Assets $71,000 USD 1.4%
Deferred Tax Assets, Net of Valuation Allowance $27,794,000 USD 18%
Share-based Payment Arrangement, Expense $1,636,000 USD 9.7%